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The variations in plasma erythropoietin (EPO) concentration during preoperative de-
posit of autologous blood were studied in 12 patients (8 men, 4 women). Four do-
nations were scheduled at weekly intervals. A predonation hemoglobin concentration 
of 11 g per dL (110 g/L) was required. Hemoglobin concentration decreased from 
14.3 ± 1.1 g per dL (143 ± 11 g/L) (mean ± SD) before the first donation to 11.7 
± 0.7 g per dL (117 ± 7 g/L) on Day 22 (p<0.0001). Reticulocyte counts increased 
from a median of 31,800 (range, 4900-95,000) per \xL (median, 32 x 10 9 /L [range, 
5-95 x 109/L]) to 93,800 (16,800-194,900) per \iL (median, 94 x 10 9 /L [range, 17-
195 x 109/L]) on Day 28 (p<0.01). Plasma E P O concentration was 17.8 ± 5.1 mU 
per mL prior to the first donation and displayed a small and transient peak after each 
donation. A sustained elevation followed each peak. Although plasma E P O concen-
tration differed significantly from the baseline value after the first donation, only the 
peak concentrations after the second (35.5 ± 15.5 mU/mL), third (38.0 ± 14.5 mU/ 
mL), and fourth (36.1 ± 1 1 . 0 mU/mL) donations exceeded the normal range. The 
moderate, biphasic increase in plasma E P O concentration and the moderate increase 
in erythropoiesis suggest two strategies in autologous blood donation that should be 
investigated with respect to efficiency and safety: 1) more aggressive donation schemes, 
which reduce donation intervals and/or the minimum hemoglobin concentration and 
2) the administration of recombinant human E P O . TRANSFUSION 1991;31:650-
654. 
Abbreviations: EPO = erythropoietin. 
T H E I M M U N O L O G I C A N D I N F E C T I O U S risks of 
transfusion1,2 can be minimized by the use of autologous 
blood. Preoperative autologous blood donation consid-
erably reduces homologous transfusion requirements in 
surgery.3"8 Frozen storage of red cells allows the pre-
operative deposit of a large number of blood units, but 
it is costly and time-consuming. On the other hand, liq-
uid storage is limited to 5 weeks for whole blood and 7 
weeks for packed red cel ls . 9 , 1 0 The efficiency of pre-
operative deposit in the liquid state thus depends on the 
rate of recovery from blood loss, that is, on the degree 
of stimulation of erythropoiesis. 
Erythropoietin (EPO) is the primary humoral regulator 
of erythropoiesis.11 Increasing the availability of EPO 
may therefore enhance the efficiency of preoperative do-
nation programs. This increased availability of EPO may 
be achieved by allowing the modulation of donation 
schemes (shorter donation intervals, lower minimum 
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predonation hematocrits) to enhance endogenous E P O 
formation. Alternatively, recombinant human E P O may 
be administered, a treatment that is effective in the man-
agement of the anemia that occurs with renal failure and 
has recently been shown to allow the withdrawal of larger 
amounts of blood from animals who are phlebotomized 
repeatedly12 and from autologous blood donors.1 3 
To obtain a rational basis for such preoperative do-
nation strategies, knowledge of the pattern of variations 
in endogenous E P O concentration following repeated 
phlebotomy would be helpful. A recent study14 sug-
gested only slight increases during preoperative deposit. 
However, in that study, E P O values were determined 
only before each donation, and thus transient increases 
may have been missed. In our investigation, we mea-
sured plasma E P O concentration both before and after 
repeated phlebotomy for autologous blood donation. 
Materials and Methods 
Patients 
With their informed consent, we studied 12 consecutive pa-
tients scheduled for hip arthroplasty or revision hip arthroplasty 
and participating in the preoperative autologous blood deposit 
program. Anemia, coronary heart disease, congestive heart 
failure, uncontrolled hypertension, severe obstructive or re-
strictive pulmonary disease, infectious disease, cerebral scle-
rosis, and syncope were considered exclusion criteria for 
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preoperative blood deposit. In addition, we excluded from the 
study patients with malignant disease and those with a serum 
creatinine level >1.3 mg per dL (100 p,mol/L). 
Of the patients studied, 8 were men, and 4 were women. 
Their mean age was 58.0 ± 10.5 ( ± SD), and the range was 
39 to 75 years. Their mean height was 167.3 ± 9.6 cm ( ± 
SD), with a range of 150 to 190 cm. Their mean weight was 
70.1 ± 15.4 kg ( ± SD), with a range of 46 to 110 kg. 
Blood donation 
The aim of the program was to obtain four donations of 450 
mL of blood at weekly intervals. A patient was deferred for 1 
week if the hemoglobin concentration prior to donation fell 
below 11 g per dL (110 g/L). Fe(-II)-aspartate tetrahydrate 
(Spartocine, U B C Chemie, Kerpen, Germany), 350 mg, was 
prescribed three times daily, a dose that corresponds to three 
doses of 50 mg of F e 2 + . 
Blood samples for blood cell counts, hemoglobin, and EPO 
determination were obtained before each donation and on the 
first, third, and fifth days thereafter. Serum iron and serum 
ferritin concentrations were determined at weekly intervals. 
The blood samples taken totalled 25 mL during the week after 
each donation appointment. 
Determination of erythropoietin 
We determined the EPO concentration in EDTA-plasma 
samples by radioimmunoassay as described previously, 1 5 using 
a rabbit antiserum derived against recombinant human EPO, 
iodinated recombinant human EPO (Amersham Laboratories, 
Amersham, UK) as a tracer and using the 2nd International 
Reference Preparation for EPO (WHO/International Labora-
tory for Biological Standards, London, UK) as a standard. The 
interassay coefficient of variation is 7 percent. The geometric 
mean EPO level for healthy adults is 17.9 mU per mL, and 
the 5 to 95 percentile is 11 to 31 mU per mL (n = 84). 
Blood cell count 
Hemoglobin concentration, red cell count, mean corpuscular 
volume, and white cell and platelet counts were determined by 
automated routine laboratory technique. Reticulocytes were 
counted manually. 
Determination of serum ferritin and serum iron 
Serum iron concentration was determined photometrically.16 
Serum ferritin concentration was determined by immunofluo-
rescence assay (normal range: men, 35-490 fig/L; women, 25-
380 |xg/L). 1 7 
Calculated values 
Blood volume was estimated according to equations (la) and 
( lb ) . 1 8 
P B V = 0.0236 x H 0 - 7 2 5 x W 0 4 2 5 - 1.229 (men) (la) 
P B V = 0.0248 x H 0 - 7 2 5 x W 0 - 4 2 5 - 1.954 (women) (lb) 
where P B V = predicted blood volume, H = height (cm), and 
W = weight (kg). 
Red cell volume was estimated according to equation (2). 1 9 
to donation did not change in the course of preoperative de-
posit, 2 0 was estimated according to equation (3). 
E V = P B V x Hct x 0.896 (2) 
where E V = red cell volume and Hct = hematocrit (venous). 
The recovery from red cell loss between donations, given 
that the hematocrit of the donated blood corresponded to that 
before donation and that the blood volume of each patient prior 
E R ^ = EV, 
+ DV„ 
(EV„ + 1 
x Hct„ x 0.985) (3) 
where E R n / n + 1 = recovery from red cell loss between the nth 
and (n 4- l)th donations, E V n and E V = red cell volume at the 
nth and (n + l)th donations, D V n = the volume donated at the 
nth donation, and Hct n = (venous) Hct before the nth donation. 
Statistics 
The data were analyzed via statistical software.21 Sample 
distribution was tested for normality as described by Shapiro-
W i l k . 2 2 Samples were compared by the paired t test or the 
Wilcoxon signed-rank test, as appropriate. The significance 
level was set at 5 percent. 
Results 
The mean calculated blood volume in these 12 patients was 
4550 ± 904 mL ( ± SD), and the range was 2819 to 6580 
mL. The mean red cell volume before the first donation was 
1646 ± 446 mL ( ± SD), and the range was 809 to 2519 mL. 
At the first and second appointments, all 12 patients donated 
1 unit of blood; at the third appointment, 10 patients donated 
blood, and at the fourth appointment, 8 patients did so. A total 
of 4 units was preoperatively deposited by each of 8 patients, 
as was a total of 3 units by each of 2 patients and 2 units by 
each of another 2 patients. 
The pattern of variation in the hemoglobin concentration is 
shown in Fig. 1. Repeated phlebotomies led to a gradual de-
crease in hemoglobin concentration from 14.3 g per dL (143 
g/L) (mean) to 13.2, 12.6, 11.9, and 11.7 g per dL (132, 126, 
119, and 117 g/L) (mean). Recovery from red cell loss by 
increased erythropoiesis can be estimated as 70 mL of red cells 
during the week after the first donation and 98 mL during the 
week following the fourth donation appointment. Reticulocyte 
count increased from a median of 31,800 (median, 32 x 109/ 
H b 
(g/di) 
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F I G . 1. Hemoglobin concentration during autologous deposit (n = 
12). Values are presented as mean ± SD. f indicates donation ap-
pointments; number of patients donating 1 unit of blood: Day 0, 12; 
Day 7, 12; Day 14, 10; Day 21, 8. *p<0.01, tp^O.001, *p<;0.0001 
vs. baseline value. 
6 5 2 L O R E N T Z ET A L . 
TRANSFUSION 
Vol. 31, No. 7-1991 
EPO 
(mU ml) 
60 
40 
30 
20 
* * * t t t t § t t t § * * t 
0 1 3 5 7 8 10 12 W C 17 19 2 1 2 2 2 4 2 6 2 8 
DAY 
F I G . 2. Plasma immunoreactive EPO concentration during autolo-
gous deposit (n = 12). Values are represented as mean ± SD; 5 to 
95 percentile of healthy adults (11-31 mU/mL). t indicates donation 
appointments; number of patients donating 1 unit of blood: Day 0, 
12; Day 7,12; Day 14,10; Day 21, 8. *p<0.05, t p ^ O . O l , *p<0.001, 
and § p < 0.0001 vs. baseline value. 
L) (range, 4900-95,000) per |xL (range, 5-95 x 10 9/L) before 
the first donation to a median of 93,800 (94 x 107L) (range, 
16,800-194,900) per |xL (17-195 x 109/L) on Day 28 (p<0.01). 
Platelet and white cell counts did not change significantly. 
Plasma EPO concentration before the first blood donation 
amounted to 17.8 ± 5 . 1 mU per mL (mean ± SD). As shown 
in Fig. 2, plasma EPO concentration displayed a small, tran-
sient peak after the first donation, a more pronounced peak 
after the second donation, and a longer-lasting peak after the 
third and fourth donations. A sustained elevation followed each 
peak. Although plasma EPO concentration was significantly 
elevated after the first donation, only those peak concentrations 
following the second, third, and fourth donations exceeded the 
normal range. 
Of the variables associated with iron metabolism, serum iron 
concentration decreased significantly from 17.2 ± 5.6 [xmol 
per L (mean ± SD) before deposit to 10.5 ± 3.4 jxmol per 
L on Day 28 (p<0.01). Serum ferritin concentration decreased 
significantly from a median of 170 (range, 40-400) \xg per L 
to 50 (range, 20-210) u.g per L (p<0.01). Mean corpuscular 
volume (88 ± 4 \xm3 [88 ± 4 fL] prior to donation vs. 89 ± 
5 ^ m 3 [89 ± 5 fL] on Day 28), and mean corpuscular hemo-
globin (31 dt 2 pg vs. 32 ± 2 pg) did not change significantly 
during the time of investigation. 
Discussion 
After blood donation, blood volume is restored within 
48 to 72 hours.2 3"2 5 The gradual fall of the hemoglobin 
concentration after each donation in our study complies 
with these results. Recovery from red cell loss, however, 
is slow in patients who exhibit the range of hemoglobin 
concentrations usually required for autologous donations 
(>11 g/dL [>110 g /L]) . 2 6 ' 2 7 This limits their ability to 
make preoperative blood deposits, if liquid storage is 
used. Donations are usually scheduled in weekly inter-
va ls . 2 8 ' 2 9 If this donation scheme were used for patients 
from whom 3 blood units were requested, 12 percent of 
the male patients and 35 percent of the females would 
have been deferred at least once in a previous study.4 
The average number of preoperatively deposited units 
per patient was 2.8, 4 whereas other preoperative dona-
tion programs have obtained only 2.2 units. 3 0 
The rate of recovery from red cell loss depends on the 
degree of stimulation of erythropoiesis, of which EPO 
is considered to be the main regulator.11 Our results in 
the patients studied show that acute reduction of the blood 
volume by 450 mL caused a biphasic increase of plasma 
EPO levels. A peak concentration was measured 24 hours 
after donation, which preceded the lowest hemoglobin 
concentration. The EPO concentration then showed a 
plateau at lower, but still elevated levels from Day 3 to 
Day 7 after the first and second donations and from Day 
5 to Day 7 after the third and fourth donations. A recent 
study in patients preoperatively donating autologous blood 
also found only a small rise in serum EPO concentration 
following phlebotomy. The serum EPO concentration 
was significantly different from the baseline value in 
female donors before the second donation and in male 
donors before the third donation. No serial measure-
ments were performed.14 
A biphasic increase of EPO levels has also been ob-
served in man 3 1 - 3 3 and rodents 3 1 ' 3 4 , 3 5 upon exposure to 
continuous normobaric or hypobaric hypoxia. The rea-
son for the early decline, which occurs before red cell 
volume increases, is not known. It appears not to be due 
to a short loop feedback control mechanism of EPO se-
cretion through direct inhibition or via its target cells. 3 6 
It may result from an adaptation to hypoxia at EPO's 
cellular production sites or from compensatory mecha-
nisms that increase oxygen availability, such as an in-
crease in cardiac output or a decrease in oxygen affinity 
of hemoglobin. 3 7 ' 3 8 
Irrespective of the cause of the specific temporal pat-
tern of EPO concentration associated with phlebotomy, 
the observation that EPO levels and therefore EPO pro-
duction respond to slight changes in oxygen availability 
is physiologically important. This finding supports the 
concept that the normal plasma EPO levels in healthy 
persons are the result of oxygen-dependent EPO pro-
duction. However, the change in EPO production in re-
lation to changes in the hemoglobin concentration is not 
constant throughout the range of hemoglobin concentra-
tions. In this study, we found a sustained increase in 
plasma EPO of 10.2 mU per mL upon lowering the 
normal hemoglobin concentration by 2.1 g per dL (21 
g/L). The same absolute reduction of hemoglobin, start-
ing from values <10 g per dL (<100 g/L), would in-
crease EPO levels by 100 mU per mL and more. 3 9 Thus, 
the sensitivity of EPO secretion to changes in the hemo-
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globin concentration appears rather low, in the range of 
low-normal to slightly subnormal hemoglobin values. 
The rate of erythropoiesis can be increased to twice 
normal or more if the hematocrit is lowered to 32 to 37 
percent (0.32-0.37).4 0 A total of 500 mL of blood can 
be donated in weekly intervals if iron is given orally in 
high dosage. After repeated donations, the hematocrit 
stabilizes near 30 percent (0.30). 2 5 In our patients, we 
found a drop in the hemoglobin concentration of 15 per-
cent 1 week after the fourth donation. The decline in 
hemoglobin concentration was associated with an in-
creased erythropoiesis, as reflected by the elevation in 
reticulocyte counts and the estimated recovery from red 
cell loss. Whereas reticulocytosis represents both in-
creased erythropoiesis and premature release of red cells 
from the bone marrow, 4 1 the estimated recovery of red 
cell volume indicates a stimulation of erythropoiesis to 
twice the normal rate. 
The oral iron supplementation prescribed constitutes 
a compromise between desirable dosage and low patient 
compliance resulting from gastrointestinal side ef-
fects. 6 , 4 2 The drop in serum iron and serum ferritin con-
centrations shows that iron absorption cannot cope with 
increased demand. The serum ferritin concentrations 
measured, however, are usually not associated with de-
pleted iron stores.43 It has also been demonstrated that, 
within the range of hemoglobin concentrations attained 
in the present study, sufficient iron for erythropoiesis 
can be supplied either from full iron stores or—in pa-
tients with little or no storage iron—from high-dose oral 
iron medication alone. 4 0 Thus, iron availability was 
probably not the factor that limited erythropoiesis. 
In the absence of iron deficiency, erythropoiesis is 
mainly determined by the availability of E P O . 1 1 As the 
increase in EPO concentration and the stimulation of 
erythropoiesis are only moderate following repeated 
phlebotomy, different strategies may be adopted to in-
crease EPO levels and erythropoiesis. 
1. The application of exogenous recombinant human 
EPO has been shown to accelerate the recovery of red 
cell volume in phlebotomized animals1 2 as well as in 
autologous blood donors.1 3 Its use in healthy persons, 
however, is still hampered by the facts that not all side 
effects of the recombinant hormone may yet be known 
and that the reported side effects 4 4 , 4 5 are not completely 
understood in regard to their causal mechanisms. If these 
concerns are overcome with increased experience in the 
treatment of chronic anemia with recombinant human 
EPO, its use may acquire a place in preoperative au-
tologous blood donation. 
2. It is tempting to speculate that modified donation 
schemes may result in more efficient stimulation of 
erythropoiesis. Reducing the time between donations, to 
3 days, for example, may lead to the occurrence of EPO 
peak concentrations at shorter intervals. In view of the 
exponential inverse relationship between EPO levels and 
hematocrit, a reduction in the minimum predonation he-
matocrit could lead to a more significant increase in EPO 
concentrations. Whether such donation schemes do in-
deed increase EPO levels and erythropoiesis during au-
tologous blood donation and decrease perioperative 
homologous blood requirements, and whether a lower 
minimum predonation hematocrit is acceptable in certain 
groups of patients remain to be investigated. 
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